Professional Bio
Xiao-Ou Shu, MD, PhD, is an Ingram Professor of Cancer Research and Professor in the Division of Epidemiology in the Department of Medicine at Vanderbilt University Medical Center, co-leader for the Cancer Epidemiology Program, and associate director for Global Health at the Vanderbilt-Ingram Cancer Center.
She received her training in Preventive Medicine and Public Health from the Fudan University School of Public Health in China, and her PhD in Epidemiology from Columbia University in New York. She has been consistently funded by the US National Institutes of Health since 1996, serving as the principal investigator for 24 major research grants and four training grants.
Dr. Shu has over 38 years of experience in conducting large-scale epidemiological studies on cancer and other chronic diseases. She is the PI of the Shanghai Men's Health Study and a leading investigator of the Shanghai Women's Health Study, two cohorts that contribute over 130,000 participants to the Asia Cohort Consortium and NCI Cancer Cohort Consortium. She is a founding member of several large epidemiological consortia, including the After Breast Cancer Pooling Project (ABCPP; N=18,000), the Asian Genetic Epidemiology Network for Obesity-Related Traits (AGEN-Obesity; N=134,500), and the Diet and Lung Cancer Pooling Project (N=1,900,000), for which she is the lead investigator.
She has more than 1,100 publications in peer-reviewed life science journals, investigating the influence of a wide range of exposures, such as nutrition/diet, lifestyle, occupational and environmental exposure, and early life exposures, as well as host susceptibility and the etiology and progression of cancer and other non-communicable chronic diseases.
Dr. Shu is leading research to discover biomarkers for pancreatic cancer early detection and risk assessment (R01 CA227133) and biomarkers for biliary track cancer risk assessment (U01 CA262678). She co-leads two cohort studies to investigate lifestyle, socioenvironmental, and genetic contributions to sarcoma treatment responses and survival (UG3 /UH3CA260318) and to investigate the role of the gut microbiome in colorectal cancer etiology after bariatric surgery (R01 CA275864). Dr. Shu is the PI for Vanderbilt Training Grant in the Molecular and Genetic Epidemiology of Cancer (MAGEC, T32 CA160056) and the contact PI for the Vanderbilt-Zambia Cancer Research Training Program (VZCARE, D43 CA270474).
Relevant Links
Education
MD - Shanghai Medical University, 1984
MPH - Shanghai Medical University, 1987
PhD - Columbia University in the City of New York, 1993
Contact
Email
Kimryn.Rathmell@Vumc.Org
Address
777 Preston Research Building
2220 Pierce Ave
Nashville, TN 37232-6307